Anlotinib Plus Pemetrexed or Pemetrexed for Previously Untreated Elderly (>=70) or PS=2 Non-squamous NSCLC
Clinical trial NCT03768037 · UNKNOWN
Trial details
- NCT number
- NCT03768037
- Sponsor
- Guangdong Association of Clinical Trials
- Status
- UNKNOWN
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2018-11-26
- Primary completion
- 2019-11-26
- Enrollment
- 106
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.